G9294 – Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

Long description

Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

Short description

Pt cat and thck on report

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

M5B Specialist - psychiatry

Added

January 1, 2014

Last change

January 1, 2014 – No change

Nearby G codes

• G9286 – Antibiotic regimen prescribed within 10 days after onset of symptoms
• G9287 – Antibiotic regimen not prescribed within 10 days after onset of symptoms
• G9288 – Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)
• G9289 – Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
• G9290 – Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
• G9291 – Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos
• G9292 – Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
• G9293 – Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
• G9295 – Specimen site other than anatomic cutaneous location
• G9296 – Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure
• G9297 – Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given
• G9298 – Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)
• G9299 – Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)
• G9300 – Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)
• G9301 – Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet
• G9302 – Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given